Skip to main content

Edelman Joseph's Form 4 filing

Chembio Diagnostics, Inc. (CEMI) · filed Apr 20, 2023

Accession no.
0000899243-23-011511
Filed
Apr 20, 2023, 7:43 PM ET
Trade date
Apr 18-20, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions. Open-market purchases total $93.7K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Edelman JosephCIK 000116442610% Owner
Perceptive Advisors LLCCIK 000122496210% Owner
Perceptive Credit Advisors, LLCCIK 000187708110% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 18, 2023Common StockPPurchaseAcquired+15,800$0.448+$7,078.44,726,334Indirect
Apr 19, 2023Common StockPPurchaseAcquired+137,000$0.448+$61,3764,863,334Indirect
Apr 20, 2023Common StockPPurchaseAcquired+56,000$0.45+$25,2004,919,334Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)